clinical_trials
ADC Scores 'Impressive' Survival Win in Heavily Pretreated Gastroesophageal Cancer
Confidence86·multiple reportsImportance88NP-EVT-20261028-D73CE0D
(MedPage Today) -- Overall survival (OS) in heavily pretreated gastroesophageal carcinoma (GEC) doubled in patients who received an investigational antibody-drug conjugate (ADC) targeting claudin (CLDN) 18.2, a randomized trial showed. Patients...
Read the original at the primary source
ADC Scores 'Impressive' Survival Win in Heavily Pretreated Gastroesophageal Cancer
10/28/2026, 3:58:02 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —